On May 21, Amphenol rose 3.03% in regular trading, trading at $122.975/share, with trading volume of $917 million. The gain marks a recovery following a multi-session selloff driven by margin dilution concerns related to its CCS acquisition integration.

On the news front, since releasing its latest quarterly earnings on April 29, Amphenol has faced persistent market concerns over profit margin dilution stemming from its CCS integration. The stock experienced a sustained post-earnings decline, falling 3.18% on May 13 and 3.11% on May 15, before dropping another 3.14% on May 18 amid broader industry weakness. The current rebound mirrors a similar pattern observed on May 14, when the stock rose 3.16% as near-term concerns were temporarily digested. Trading volume of $917 million suggests active institutional participation in the recovery.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)